FDA applicant
Endologix, Inc.
FDA records 9 decisions for Endologix, Inc. (Irvine, CA) from 1998 to 2023: 5 510(k) clearances and 4 original PMA approvals. Most are in product codes DYB (Introducer, Catheter) and DQY (Catheter, Percutaneous). Its devices cite 7 predicates, 4 of them its own earlier devices. 20 recalls are linked to its devices, 3 Class I.
FDA’s records also spell it “Endologix, LLC”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Endologix, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
1in 2020
Class I Class II/III not classified
Planning a device like Endologix, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report